Why Dentists in California Are Dumping Oxymorphone and Other Dental Painkillers
The last week has been tough for dentists in Southern California.
The state has been facing a crisis of opioid addiction, and the opioid epidemic is also driving up the cost of care.
A new bill passed by the state legislature would allow dental offices to sell Oxymorphones, an opioid painkiller that’s been used in more than 20 states.
In California, which is one of only a handful of states that allows prescription opioids for chronic pain, there have been at least 14 deaths linked to Oxymorone over the last few weeks.
In some cases, patients have died after being prescribed Oxymoron.
On Wednesday, state health officials said they had found more than 100 deaths, and were investigating how to treat those patients.
While the state has yet to determine how much Oxymoronic the drugs are sold for, it’s estimated that as many as 30 percent of dentists prescribe Oxymorones for chronic dental pain.
The drug was first developed in the 1980s by a Swiss pharmaceutical company called Novartis.
Its sales are growing rapidly, and its brand has grown to include Oxymoro, as well as OxyContin, OxyNEO and other brands.
The brand has been sold for years in Canada and Australia, where it’s also sold over-the-counter.
A New York Times investigation found that over a three-year period, the drug was found in almost half of all prescriptions from more than 1,500 dentists.
The drugs are often prescribed for chronic conditions like sinus infections, pain from a toothache, dental problems, chronic back pain and more.
It’s not the first time the opioid crisis has led to dentists abandoning their traditional prescribing.
The crisis has hit the state hard, too.
In 2016, the state experienced its worst year of opioid overdoses, with more than 40,000 people dying from opioid overdoses in the state.
In 2017, it was the most deadly year on record, with over 3,400 people dying, according to the Centers for Disease Control and Prevention.
Dentists are now faced with the difficult task of filling the dentists’ vacancy.
Dentist unions have called for more access to Oxy, as has the state’s Democratic Party.
But the legislature’s vote to allow prescription painkillers has made the issue more difficult for dentistry unions.
The bill passed on Wednesday by the Assembly committee that handles health and public safety would allow dentists to sell over-Themed Oxymoroni, which would include Oxycodone, Oxycodas, OxyContin and Oxymorol.
The measure is sponsored by Assemblymember José E. Hernandez (D-Bell Gardens), who is also the state senator for the Orange County district where he lives.
He said the measure would allow patients to get Oxymoronia and then turn it into a more traditional oral prescription.
The move would allow the state to keep the dentistry industry viable.
Hernandez said it’s important for dentures to have a prescription painkiller because the dentures have so much to lose financially from a lack of sales.
He’s hopeful that dentists will continue to prescribe the medication to patients.
The painkiller is already available for $20 a day, Hernandez said.
He is calling on the state government to stop the opioid abuse crisis and to fund the treatment of chronic pain.
“The current situation in California has reached crisis point,” Hernandez said in a statement.
“I’m asking for the state of California to invest $1.7 billion in chronic pain and addiction treatment, and to pay for it by cutting its opioid addiction rates by at least 10 percent.”